(Q46722744)

24 December 2017

title

Epigenetic repression of RASSF1A but not CASP8 in supratentorial PNET (sPNET) and atypical teratoid/rhabdoid tumors (AT/RT) of childhood (English)

1 reference

24 December 2017

author name string

J Mühlisch

1

1 reference

24 December 2017

A Schwering

2

1 reference

24 December 2017

M Grotzer

3

1 reference

24 December 2017

G H Vince

4

1 reference

24 December 2017

W Roggendorf

5

1 reference

24 December 2017

C Hagemann

6

1 reference

24 December 2017

N Sörensen

7

1 reference

24 December 2017

C H Rickert

8

1 reference

24 December 2017

N Osada

9

1 reference

24 December 2017

H Jürgens

10

1 reference

24 December 2017

M C Frühwald

11

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

24 December 2017

published in

Oncogene

1 reference

24 December 2017

volume

25

1 reference

24 December 2017

issue

7

1 reference

24 December 2017

page(s)

1111-1117

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209137

exact match

0 references

cites work

Role of the Ras-association domain family 1 tumor suppressor gene in human cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209137

Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209137

Molecular analysis of a partial deletion of 22q in a central nervous system rhabdoid tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209137

Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209137

Epigenetics in human disease and prospects for epigenetic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209137

Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas--implications for tumor biology and potential clinical utility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209137

Gene amplification in PNETs/medulloblastomas: mapping of a novel amplified gene within the MYCN amplicon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209137

Global and gene-specific methylation patterns in cancer: aspects of tumor biology and clinical potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209137

Somatostatin receptor subtype 2 is expressed by supratentorial primitive neuroectodermal tumors of childhood and can be targeted for somatostatin receptor imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209137

Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209137

The WHO classification of tumors of the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209137

Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209137

Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209137

The theoretical basis of transcriptional therapy of cancer: can it be put into practice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209137

Atypical teratoid/rhabdoid tumor of the central nervous system: report on workshop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209137

Chromosomal imbalances detected by comparative genomic hybridisation in atypical teratoid/rhabdoid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209137

Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209137

Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209137

No evidence for hypermethylation of the hSNF5/INI1 promoter in pediatric rhabdoid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209137

Loss of caspase-8 mRNA expression is common in childhood primitive neuroectodermal brain tumour/medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209137

Expression and methylation of CASP8 in neuroblastoma: identification of a promoter region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209137

7 January 2021

TrkC expression predicts good clinical outcome in primitive neuroectodermal brain tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209137

7 January 2021

Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209137

7 January 2021

Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209137

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209137

1 reference

24 December 2017

Dimensions Publication ID

1014854938

0 references

1 reference

24 December 2017